LSV Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Buy |
|
|||||
|
2025
Q1 | $33.1M | Buy |
|
|||||
|
2024
Q4 | $35.9M | Buy |
|
|||||
|
2024
Q3 | $8.04M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $30.3M | Sell |
|
|||||
|
2023
Q3 | $88.6M | Sell |
|
|||||
|
2023
Q2 | $101M | Sell |
|
|||||
|
2023
Q1 | $102M | Buy |
|
|||||
|
2022
Q4 | $99.4M | Sell |
|
|||||
|
2022
Q3 | $98.6M | Sell |
|
|||||
|
2022
Q2 | $75.5M | Sell |
|
|||||
|
2022
Q1 | $78.7M | Buy |
|
|||||
|
2021
Q4 | $85.2M | Sell |
|
|||||
|
2021
Q3 | $102M | Buy |
|
|||||
|
2021
Q2 | $125M | Sell |
|
|||||
|
2021
Q1 | $257M | Sell |
|
|||||
|
2020
Q4 | $230M | Sell |
|
|||||
|
2020
Q3 | $281M | Sell |
|
|||||
|
2020
Q2 | $270M | Sell |
|
|||||
|
2020
Q1 | $340M | Sell |
|
|||||
|
2019
Q4 | $332M | Buy |
|
|||||
|
2019
Q3 | $260M | Buy |
|
|||||
|
2019
Q2 | $250M | Buy |
|
|||||
|
2019
Q1 | $218M | Buy |
|
|||||
|
2018
Q4 | $235M | Buy |
|
|||||
|
2018
Q3 | $268M | Buy |
|
|||||
|
2018
Q2 | $172M | Buy |
|
|||||
|
2018
Q1 | $154M | Buy |
|
|||||
|
2017
Q4 | $157M | Buy |
|
|||||
|
2017
Q3 | $152M | Buy |
|
|||||
|
2017
Q2 | $121M | Buy |
|
|||||
|
2017
Q1 | $9.4M | Buy |
|
|||||
|
2016
Q4 | $8.81M | Buy |
|
|||||
|
2016
Q3 | $8.18M | Buy |
|
|||||
|
2016
Q2 | $5.13M | Buy |
|
|||||
|
2016
Q1 | $2.66M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $178K | Buy |
|